Market Closed -
London S.E.
11:35:08 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
0.6
GBX
|
0.00%
|
|
0.00%
|
-7.69%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
7.07
|
5.258
|
9.267
|
18.9
|
18.79
|
17.52
|
Enterprise Value (EV)
1 |
6.754
|
4.932
|
8.976
|
17.83
|
17.93
|
17.14
|
P/E ratio
|
-15.6
x
|
-8.83
x
|
-22.3
x
|
-42.8
x
|
-84.2
x
|
-39.7
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
30
x
|
16.3
x
|
26.6
x
|
37.4
x
|
44.1
x
|
44.9
x
|
EV / Revenue
|
28.6
x
|
15.3
x
|
25.8
x
|
35.3
x
|
42.1
x
|
44
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-36
x
|
-26.8
x
|
-51.1
x
|
-140
x
|
-112
x
|
-43.3
x
|
FCF Yield
|
-2.78%
|
-3.73%
|
-1.96%
|
-0.72%
|
-0.89%
|
-2.31%
|
Price to Book
|
8.99
x
|
6.45
x
|
11.4
x
|
11.4
x
|
12.5
x
|
14.7
x
|
Nbr of stocks (in thousands)
|
1,885,238
|
1,983,988
|
2,059,322
|
2,210,822
|
2,210,822
|
2,217,822
|
Reference price
2 |
0.003750
|
0.002650
|
0.004500
|
0.008550
|
0.008500
|
0.007900
|
Announcement Date
|
9/27/18
|
9/10/19
|
9/30/20
|
9/30/21
|
9/30/22
|
9/30/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.2358
|
0.3222
|
0.3479
|
0.5053
|
0.4262
|
0.3899
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-0.4679
|
-0.5339
|
-0.4248
|
-0.3595
|
-0.2992
|
-0.4209
|
Operating Margin
|
-198.44%
|
-165.71%
|
-122.09%
|
-71.13%
|
-70.21%
|
-107.95%
|
Earnings before Tax (EBT)
1 |
-0.4674
|
-0.5334
|
-0.4245
|
-0.3593
|
-0.2991
|
-0.4199
|
Net income
1 |
-0.4481
|
-0.513
|
-0.4062
|
-0.341
|
-0.2242
|
-0.3852
|
Net margin
|
-190.03%
|
-159.23%
|
-116.75%
|
-67.48%
|
-52.62%
|
-98.8%
|
EPS
2 |
-0.000241
|
-0.000300
|
-0.000202
|
-0.000200
|
-0.000101
|
-0.000199
|
Free Cash Flow
1 |
-0.1877
|
-0.1838
|
-0.1757
|
-0.1276
|
-0.1603
|
-0.3958
|
FCF margin
|
-79.6%
|
-57.06%
|
-50.49%
|
-25.26%
|
-37.62%
|
-101.51%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
9/27/18
|
9/10/19
|
9/30/20
|
9/30/21
|
9/30/22
|
9/30/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
0.32
|
0.33
|
0.29
|
1.08
|
0.86
|
0.38
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-0.19
|
-0.18
|
-0.18
|
-0.13
|
-0.16
|
-0.4
|
ROE (net income / shareholders' equity)
|
-264%
|
-160%
|
-129%
|
-49.2%
|
-22.8%
|
-47.6%
|
ROA (Net income/ Total Assets)
|
-101%
|
-75.8%
|
-57.1%
|
-25.5%
|
-15.5%
|
-26.7%
|
Assets
1 |
0.4419
|
0.677
|
0.7121
|
1.337
|
1.451
|
1.445
|
Book Value Per Share
2 |
0
|
0
|
0
|
0
|
0
|
0
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
0
|
0
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
9/27/18
|
9/10/19
|
9/30/20
|
9/30/21
|
9/30/22
|
9/30/23
|
|
1st Jan change
|
Capi.
|
---|
| -7.69% | 16.91M | | +8.20% | 7.78B | | +0.34% | 7.38B | | +10.20% | 6.52B | | -8.10% | 3.67B | | -14.57% | 1.17B | | +8.34% | 934M | | -42.27% | 879M | | -18.90% | 836M | | -16.45% | 802M |
Special Foods & Wellbeing Products
|